Multiple myeloma: open trials in Serbia

• NCT05243797

  Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

  Trial Treatment · Phase 3 · European Myeloma Network B.V.

  University Clinical Center of Serbia, Belgrade · Clinical Centre of Kragujevac, Kragujevac · Clinical Centre of Nis, Niš · Clinical Centre of Vojvodina, Novi Sad

  Registry updated 2026-10-07

• NCT05645107

  A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

  Trial Treatment · Phase 3 · Grifols Therapeutics LLC

  Belgrade · Belgrade · Belgrade · Belgrade · Kamenitz · Kragujevac · Niš

  Registry updated 2026-09-30

• NCT07477587

  A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

  Trial Treatment · Phase 1 · Shanghai Henlius Biotech

  Clinical Hospital Centre Zemun, Belgrade · University Clinical Center Kragujevac, Kragujevac · University Clinical Center NIS, Niš

  Registry updated 2026-09-24

• NCT04077307

  A Study in Leukemia Patients With Karonudib

  Trial Treatment · Phase 1 · Thomas Helleday Foundation

  University Clinical Center Belgrade, Belgrade · Vojnomedicinska akademija, Klinika za hematologiju, Belgrade · University Clinical Center Kragujevac, Kragujevac

  Registry updated 2026-08-06

• NCT06237803

  European Myeloma Network (EMN) Sample Project

  Research · European Myeloma Network B.V.

  Clinic of Hematology, University Clinical Center of Serbia, Belgrade

  Registry updated 2025-12-03

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error